PULSE BIOSCIENCES, INC. — Director's Dealing 2022

Sep 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2022-09-23

Reporting Person: Danahy Kevin Patrick (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-23	Stock Option (right to buy)	$1.53	A	450000	Acquired	2032-09-23	Common Stock (450000)	Direct

Footnotes

F1: The option was granted on September 23, 2022 under the Issuer's 2017 Equity Incentive Plan and pursuant to an amendment to the Reporting Person's employment agreement. The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date.

F2: Not applicable.